AIC
IRD

AWM Investment Company’s Opus Genetics IRD Stock Holding History

AWM Investment Company’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-524,245
Closed -$515K – 104
2025
Q1 		$515K Buy
+524,245
New +$586K 0.07% 86

Other funds holding IRD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AWM Investment Company's IRD Position: Q2 2025 in Review

AWM Investment Company sold out of Opus Genetics (IRD) in Q2 2025, closing a stake of 524,245 shares — an estimated $515K sold.

AWM Investment Company first reported a position in IRD in Q1 2025 and held it in 1 quarter. The position peaked at $515K in Q1 2025. 43 funds tracked by Wall St. Rank hold IRD as of Q2 2025.

  • AWM Investment Company reported no remaining Opus Genetics position as of Q2 2025 after selling out during the quarter.
  • AWM Investment Company sold 524,245 Opus Genetics shares in Q2 2025, an estimated $515K.
  • AWM Investment Company first reported a position in Opus Genetics in Q1 2025 and held it in 1 quarter.
  • AWM Investment Company's Opus Genetics position peaked at $515K in Q1 2025.
  • 43 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2025.

Based on AWM Investment Company's 13F filing for Q2 2025, filed 14 Aug 2025.